Most recent update: Sunday, April 29, 2018 - 14:56

You are here

deep vein thrombosis

Varicose veins associated with DVT incidence

Adults who were diagnosed with varicose veins have a significantly increased risk of incident deep venous thrombosis (DVT), although whether the association between varicose veins and DVT is causal or represents a common set of risk factors requires further research.

ATTRACT - clot-busting drugs do not benefit most patients with DVT

The results of the Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT) study have revealed that clot busting drugs and medical devices do not improve outcomes for patients experiencing deep vein thrombosis (DVT), nor do they prevent the development of post-thrombotic syndrome (PTS) when compared with conventional blood thinning medications.

Study shows benefits of catheter- directed thrombolysis for DVT

A study published in the Journal of Vascular Surgery Venous and Lymphatic Disorders has highlighted the benefits of catheter-directed thrombolysis (CDT) in the treatment of DVT. This is in contrast to findings in the ATTRACT (Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis) trial that suggest most patients will not benefit significantly from more aggressive treatment of DVT.

ESC publishes recommendations for DVT treatment

The first comprehensive European recommendations on deep vein thrombosis (DVVT) was recently published in the European Heart Journal, by the European Society of Cardiology (ESC) Working Group on Aorta and Peripheral Vascular Diseases and Working Group on Pulmonary Circulation and Right Ventricular Function.

ManaMed launches PlasmaFlow digital DVT prevention device

ManaMed has launched the company's first FDA-approved portable and tubeless DVT prevention device is now available to medical practitioners and patients throughout the US. Tubeless and portable, PlasmaFlow is intended for use at home or at the hospital to help prevent the onset of DVT in patients by stimulating blood flow in the extremities.

Anti-allergy medicines could be used to prevent DVT

Common anti-allergy medicines could prove to be an effective treatment for potentially fatal blood clots in the legs, according to research by the University of Birmingham. The research, funded by the British Heart Foundation, has discovered that mice genetically depleted of mast cells, a type of immune cells, are protected from developing DVT. The study could lead to new treatments that prevent deep vein thrombosis (DVT).

Cardinal Health acquires Medtronic's DVT business

Cardinal Health has completed the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business for US$6.1 billion. The Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business encompasses 23 product categories across multiple market sites of care, including numerous industry-leading brands, such as Curity, Kendall, Dover, Argyle and Kangaroo.

ACCESS PTS study shows efficacy of EKOS Therapy

The results of the ACCESS PTS (Accelerated Thrombolysis for Post-Thrombotic Syndrome Using the Ekos System) trial has reported chronic deep vein thrombosis (DVT) patients with post-thrombotic syndrome (PTS) can be treated safely and effectively with EKOS therapy. According to BTG, the ACCESS PTS protocol using EKOS therapy is now the only treatment regimen proven to significantly reduce the signs and symptoms of PTS and show a significant improvement in quality of life. The outcomes were presented at the Society for Vascular Medicine 28th Annual Scientific Sessions in New Orleans.

First patient treated with the ClotTriever Thrombectomy System

Inari Medical has announced the first patient has been treated with its ClotTriever Thrombectomy System, a non-surgical devices that removes thrombus from the peripheral vasculature. The ClotTriever system is designed to remove large clot volume from large veins via access sites as small as 6mm. The ClotTriever does not require use of thrombolytic drugs, which carry significant risk of bleeding and are contraindicated in many patients, the company said.

Most DVT patients should be treated with anticoagulant drugs alone

The results from the Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT) randomised, multi-centre clinical trial, has reported that most patients with DVT should continue to be treated with anticoagulant drugs alone, without undergoing a procedure-based intervention.

However, the study also showed that a minimally invasive catheter-directed therapy, known as pharmacomechanical catheter-directed thrombolysis (PCDT), provides greater relief of initial leg pain and swelling and is likely to prevent disability in certain DVT patients

Anti-clotting drugs unnecessary for most surgery patients

As many as three out of four surgery patients could be receiving anti-clotting medications that they do not need, according to a study led by investigators at the University of Utah School of Medicine. The research challenges standard of care guidelines specifying that all general surgery patients receive anticoagulants. The treatment is meant to prevent formation of blood clots in the veins. In the worst cases, clots could break free and block blood flow to vital organs such as the lungs, causing sudden death.

Study assessing DVT resolution, recurrence and PTS

Researchers at the University Hospitals Bristol NHS Foundation Trust and the University of the West of England, UK, are investigating the thrombus morphology, evolution and resolution in a deep vein thrombosis (DVT) patient population, in order to identify the level of variation in response to anticoagulation treatment and provide more precise and quantitative disease characterisation in response to treatment.

Congenital malformations of the inferior vena cava

Although congenital malformations of the inferior vena cava (IVC) are rare and underreported, they can be a risk factor for deep venous thrombosis (DVT) as a result of inadequate venous drainage of the lower extremities through collateral circulation.

Subscribe to RSS - deep vein thrombosis